Antimicrobial resistance: why it matters and what can be done
Antimicrobial resistance (AMR) is one of the most urgent global health challenges today. When bacteria, viruses, fungi, or parasites evolve to survive drugs designed to kill them, standard treatments become ineffective, infections last longer, complications rise, and routine medical procedures become riskier. Understanding AMR and acting on practical solutions is essential for preserving the effectiveness of life-saving medicines.
Why AMR matters
AMR reduces the effectiveness of treatments for common infections, complicates surgery and cancer care, and drives up healthcare costs. It creates longer hospital stays, higher medical bills, and increased mortality from infections that were once easily treatable. The problem also undermines food security and animal health when antibiotics used in farming lose efficacy. Because microbes do not respect borders, AMR is a shared threat that requires coordinated global response and local action.
Key drivers of resistance
– Overuse and misuse of antimicrobials in human medicine: Inappropriate prescriptions, unnecessary use for viral illnesses, and incomplete treatment courses all accelerate resistance.
– Agricultural practices: Routine use of antibiotics for growth promotion or disease prevention in livestock contributes to resistant strains that can transfer to people through food or the environment.
– Poor infection prevention and control: Inadequate water, sanitation, hygiene, and healthcare infection control allow resistant organisms to spread in communities and healthcare facilities.
– Lack of rapid diagnostics: Without quick tools to distinguish bacterial from viral infections, clinicians may prescribe antibiotics empirically, increasing unnecessary use.
– Global travel and trade: Movement of people, animals, and goods enables rapid dissemination of resistant organisms across regions.
Strategies that work
Addressing AMR requires a One Health approach that integrates human, animal, and environmental health. Practical, proven strategies include:
– Antimicrobial stewardship: Implement programs in hospitals, clinics, and veterinary settings to ensure antibiotics are prescribed only when necessary, at the right dose and duration. Stewardship teams, clinical guidelines, and prescriber feedback reduce inappropriate use.
– Strengthened surveillance and diagnostics: Investing in rapid, affordable diagnostics helps clinicians target therapy accurately and reduces empirical antibiotic use.
Robust surveillance systems detect emerging resistance patterns and guide policy decisions.
– Infection prevention and control (IPC): Improved hand hygiene, vaccination, safe water and sanitation, and robust IPC in healthcare facilities curb the spread of resistant infections.
– Responsible agricultural use: Phasing out routine antibiotic use for growth promotion, adopting veterinary stewardship, and enhancing animal husbandry and biosecurity reduce the need for antimicrobials in farming.
– Research and innovation: New antibiotics, alternative therapies (such as phage therapy and monoclonal antibodies), and novel diagnostics are critical, but must be paired with stewardship to preserve their utility.
– Policy and finance: Strong national action plans, regulatory frameworks, and sustainable financing align incentives across sectors and support long-term implementation.
What individuals can do
– Use antibiotics only when prescribed by a qualified healthcare professional and complete the full course as directed.
– Never pressure clinicians for antibiotics for viral illnesses like colds or flu; ask about alternatives and whether testing is available.
– Practice good hygiene—handwashing, safe food handling, and staying up-to-date with recommended vaccinations reduce infection risk.
– Support responsible sourcing of food and choose products that follow responsible antibiotic use standards when possible.
– Advocate for stronger policies and funding for AMR surveillance, stewardship, and access to diagnostics.
AMR is manageable if governments, health systems, industry, communities, and individuals act together. By combining smarter use of existing drugs, better prevention, stronger diagnostics, and sustained investment in new tools, the global community can slow resistance and protect the medicines that underpin modern healthcare.